chlorambucil has been researched along with Pyoderma in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Pyoderma: Any purulent skin disease (Dorland, 27th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callen, JP | 1 |
| Case, JD | 1 |
| Sager, D | 1 |
| Najmowicz-Dabrowa, H | 1 |
2 other studies available for chlorambucil and Pyoderma
| Article | Year |
|---|---|
Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Chlorambucil; Gangrene; Humans; Leg Ulcer; Mal | 1989 |
[Serious infectious complications of chronic lymphatic leukemia].
Topics: Chlorambucil; Chronic Disease; Female; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Middle | 1974 |